Prince Akwasi Mensah

Array ( [id] => 1589521 [patent_doc_number] => 06482858 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-11-19 [patent_title] => '()-hydroxycitric acid for wound healing and immunomodulation' [patent_app_type] => B1 [patent_app_number] => 09/886572 [patent_app_country] => US [patent_app_date] => 2001-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7221 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/482/06482858.pdf [firstpage_image] =>[orig_patent_app_number] => 09886572 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1453865 [patent_doc_number] => 06462029 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-08 [patent_title] => 'Compositions and methods for treating mammals with modified alginates and modified pectins' [patent_app_type] => B1 [patent_app_number] => 09/883329 [patent_app_country] => US [patent_app_date] => 2001-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3667 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/462/06462029.pdf [firstpage_image] =>[orig_patent_app_number] => 09883329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1416863 [patent_doc_number] => 06511985 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-28 [patent_title] => 'Combination of cerivastatin and fibrates' [patent_app_type] => B1 [patent_app_number] => 09/868444 [patent_app_country] => US [patent_app_date] => 2001-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2635 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/511/06511985.pdf [firstpage_image] =>[orig_patent_app_number] => 09868444 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1253646 [patent_doc_number] => 06670387 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-12-30 [patent_title] => 'Thrombopoietin mimetics' [patent_app_type] => B1 [patent_app_number] => 09/868198 [patent_app_country] => US [patent_app_date] => 2001-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12377 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 541 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/670/06670387.pdf [firstpage_image] =>[orig_patent_app_number] => 09868198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6625879 [patent_doc_number] => 20020016369 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-07 [patent_title] => 'Use of nimesulide for the treatment of psoriasis and psoriatic arhtritis' [patent_app_type] => new [patent_app_number] => 09/878910 [patent_app_country] => US [patent_app_date] => 2001-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 908 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0016/20020016369.pdf [firstpage_image] =>[orig_patent_app_number] => 09878910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 658430 [patent_doc_number] => 07105534 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-12 [patent_title] => 'Imidazo[1,2-α]pyridine ether compounds as ion channel modulators' [patent_app_type] => utility [patent_app_number] => 10/297988 [patent_app_country] => US [patent_app_date] => 2001-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 37269 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105534.pdf [firstpage_image] =>[orig_patent_app_number] => 10297988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6921777 [patent_doc_number] => 20010029262 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-11 [patent_title] => 'Method of treatment or prophylaxis' [patent_app_type] => new [patent_app_number] => 09/879462 [patent_app_country] => US [patent_app_date] => 2001-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2179 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20010029262.pdf [firstpage_image] =>[orig_patent_app_number] => 09879462 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6987353 [patent_doc_number] => 20010036948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-01 [patent_title] => 'Inhibiting proliferation of arterial smooth muscle cells' [patent_app_type] => new [patent_app_number] => 09/878831 [patent_app_country] => US [patent_app_date] => 2001-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9360 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20010036948.pdf [firstpage_image] =>[orig_patent_app_number] => 09878831 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6408592 [patent_doc_number] => 20020037902 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-28 [patent_title] => 'Use of riluzole or its salts for the prevention and treatment of adrenoleukodystrophy' [patent_app_type] => new [patent_app_number] => 09/873270 [patent_app_country] => US [patent_app_date] => 2001-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2533 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20020037902.pdf [firstpage_image] =>[orig_patent_app_number] => 09873270 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6882893 [patent_doc_number] => 20010049365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-06 [patent_title] => 'Compositions and methods of treating abnormal cell proliferation' [patent_app_type] => new [patent_app_number] => 09/872662 [patent_app_country] => US [patent_app_date] => 2001-06-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6984 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20010049365.pdf [firstpage_image] =>[orig_patent_app_number] => 09872662 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6715785 [patent_doc_number] => 20030027133 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-06 [patent_title] => 'Method of improving a mixture experiment' [patent_app_type] => new [patent_app_number] => 09/681751 [patent_app_country] => US [patent_app_date] => 2001-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 4539 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0027/20030027133.pdf [firstpage_image] =>[orig_patent_app_number] => 09681751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1595397 [patent_doc_number] => 06384064 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-05-07 [patent_title] => 'Viral treatment' [patent_app_type] => B2 [patent_app_number] => 09/871565 [patent_app_country] => US [patent_app_date] => 2001-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6968 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/384/06384064.pdf [firstpage_image] =>[orig_patent_app_number] => 09871565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6131656 [patent_doc_number] => 20020077355 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-20 [patent_title] => 'Use of epoxyeicosatrienoic acids in the treatment of cerebrovascular conditions' [patent_app_type] => new [patent_app_number] => 09/870425 [patent_app_country] => US [patent_app_date] => 2001-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6414 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20020077355.pdf [firstpage_image] =>[orig_patent_app_number] => 09870425 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6000680 [patent_doc_number] => 20020028825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Use of methylnaltrexone and related compounds' [patent_app_type] => new [patent_app_number] => 09/862169 [patent_app_country] => US [patent_app_date] => 2001-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3735 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028825.pdf [firstpage_image] =>[orig_patent_app_number] => 09862169 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5987613 [patent_doc_number] => 20020099076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-25 [patent_title] => 'Use of (+)-a-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl) ethyl]-4-piperidinemethanol or its prodrug in the treatment of symptoms of dementia and dopamine induced psychosis' [patent_app_type] => new [patent_app_number] => 09/861980 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6666 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20020099076.pdf [firstpage_image] =>[orig_patent_app_number] => 09861980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6880470 [patent_doc_number] => 20010031757 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-10-18 [patent_title] => 'Method for treating inflammatory diseases by administering a thrombin inhibitor' [patent_app_type] => new [patent_app_number] => 09/853057 [patent_app_country] => US [patent_app_date] => 2001-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10437 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20010031757.pdf [firstpage_image] =>[orig_patent_app_number] => 09853057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6889598 [patent_doc_number] => 20010025053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-27 [patent_title] => 'Use of nitric oxid synthase inhibitors for the treatment of diabetes' [patent_app_type] => new [patent_app_number] => 09/850655 [patent_app_country] => US [patent_app_date] => 2001-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 1674 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20010025053.pdf [firstpage_image] =>[orig_patent_app_number] => 09850655 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6344324 [patent_doc_number] => 20020035138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-21 [patent_title] => 'Activating Cl- secretion' [patent_app_type] => new [patent_app_number] => 09/843796 [patent_app_country] => US [patent_app_date] => 2001-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 5545 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20020035138.pdf [firstpage_image] =>[orig_patent_app_number] => 09843796 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1298452 [patent_doc_number] => 06627663 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-30 [patent_title] => 'Noninvasive method for treating hemangiomas through transdermal delivery of calcium channel blocker agents and medicament for use in such method' [patent_app_type] => B2 [patent_app_number] => 09/839570 [patent_app_country] => US [patent_app_date] => 2001-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2308 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/627/06627663.pdf [firstpage_image] =>[orig_patent_app_number] => 09839570 [rel_patent_id] =>[rel_patent_doc_number] =>)